US Stem Cell Inc (USRM)

[MyzStreet]

UNDER PATENT PROTECTION: METHOD OF OBTAINING CELLS AND GROWING W/ ELECTROSTIMULATION


Who is the 2 patents assigned to ?

USRM's board of directors, by way of Northstar Biotech Group LLC.

CRT Bi-V pacers sold by Medtronic, St. Jude and Boston Scientific-Guidant, Biotronik and Sorin Biomedica provide on average about 20 meters improvement in exercise capacity testing. Sales of CRT Bi-V pacers are expected to exceed $6 billion this year. Bioheart MyoCell beats their performance by nearly 500%.

95.7 TO 52 BIOHEART MYOCELL BEATS MESOBLAST MPCS IN SIDE BY SIDE PHASE II/III CLINICAL TRIAL PERFORMANCE IN THE PRIMARY END POINT MEASURE OF EXERCISE CAPACITY IMPROVEMENT IN HEART FAILURE PATIENTS VIA 6 MIN. WALK TESTING.

95.7 TO 53 BIOHEART MYOCELL BEATS CARDIO3 C-CURE CARDIAC STEM CELLS IN SIDE BY SIDE COMPARISON – 6 MIN. WALK.

95.7 TO 53 BIOHEART MYOCELL BEATS CAPRICOR CARDIAC STEM CELLS IN SIMILAR CLINICAL STUDIES – 6 MIN. WALK.

95.7 TO 10 BIOHEART MYOCELL BEAT OSIRIS/HARE ALLOGENEIC BONE MARROW DERIVED STEM CELLS IN SIMILAR CLINICAL STUDIES – 6 MIN. WALK.